Literature DB >> 31162742

Structural abnormalities in hypertrophic cardiomyopathy beyond left ventricular hypertrophy by multimodality imaging evaluation.

Jose Angel Urbano-Moral1,2, Laura Gutierrez-Garcia-Moreno1, Jose Fernando Rodriguez-Palomares1, Javier Matabuena-Gomez-Limon2, Natalia Niella1,3, Giuliana Maldonado1, Juan Ignacio Valle-Racero2, Marcela Niella3, Gisela Teixido-Tura1, David Garcia-Dorado1, Paolo Ferrazzi4, Natesa G Pandian5,6, Arturo Evangelista-Masip1.   

Abstract

BACKGROUND: Echocardiography- and cardiovascular magnetic resonance (CMR)-based studies have revealed a wide range of phenotypic manifestations in hypertrophic cardiomyopathy (HCM) apart from hypertrophy. This study sought to comprehensively describe a number of structural abnormalities in HCM beyond hypertrophy, by multimodality imaging.
METHODS: A total of 100 HCM patients were prospectively enrolled, undergoing standard and contrast echocardiography, and CMR. Morphological characteristics involving mitral valve leaflets (MVL), subvalvular apparatus, and left ventricular cavity and wall were investigated. Seventy healthy volunteers served as control population.
RESULTS: As assessed by echo, MVLs were longer in HCM patients than in controls (anterior method 1: 24[22,28] vs 19[18,20] mm, P < 0.01; anterior method 2: 27[24, 29] vs 21[19, 23] mm, P < 0.01; posterior: 15[12,19] vs 14[13,15] mm, P < 0.01). Abnormal chordal attachment to anterior MVL, anterior papillary muscle displacement, and accessory apical-basal muscle bundle were present in 42 (42%), 61 (61%), and 35 (35%) patients, respectively (P values vs controls <0.01); direct papillary muscle insertion into MVL and hypertrabeculation were found in two and five patients, respectively. Contrast echocardiography (n = 94) detected myocardial crypts in 15 patients (16%). Overall, 83% of HCM subjects had at least one of these phenotypic manifestations. Echocardiography and CMR agreement for MVL length was poor, while for structural characteristics was moderate to substantial (Cohen's Kappa: 0.53-1.00). Except for posterior MVL length and hypertrabeculation, the phenotypic characteristics studied had acceptable reproducibility by echocardiography and CMR.
CONCLUSIONS: Structural abnormalities in HCM beyond hypertrophy are significantly common. Multimodality imaging approach to these HCM facets by echocardiography and CMR is feasible and desirable.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac magnetic resonance imaging; contrast echocardiography; echocardiography; hypertrophic cardiomyopathy; mitral valve

Mesh:

Substances:

Year:  2019        PMID: 31162742     DOI: 10.1111/echo.14393

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  4 in total

Review 1.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae-A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy.

Authors:  Lucian Florin Dorobantu; Toma Andrei Iosifescu; Razvan Ticulescu; Maria Greavu; Maria Alexandrescu; Andrei Dermengiu; Miruna Mihaela Micheu; Monica Trofin
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

Review 3.  Multimodality Cardiac Imaging in Cardiomyopathies: From Diagnosis to Prognosis.

Authors:  Guillem Casas; José F Rodríguez-Palomares
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

Review 4.  Comprehensive left ventricular outflow tract management beyond septal reduction to relieve obstruction.

Authors:  Lara Gharibeh; Nicholas G Smedira; Juan B Grau
Journal:  Asian Cardiovasc Thorac Ann       Date:  2021-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.